Uterine fibroids are abnormal growths that develop in the uterus, consisting of fibrous connective tissue and muscle cells. These non-cancerous tumors can vary in size and may lead to severe abdominal pain and heavy menstrual bleeding. Often, fibroids are asymptomatic and can be challenging to detect.
Research indicates that approximately 80% of women experience fibroid growth at some point, with varying prevalence rates. Treatments are available to alleviate symptoms and manage the condition. Uterine fibroids are also known as uterine myomas, leiomyomas, fibromas, and myom
Fibroids are non-cancerous tissue masses that typically develop within the uterine wall or its surface. Their size can vary widely, from as small as a seed to as large as a watermelon.
Symptoms of fibroids can range from none at all to several, including painful intercourse and pelvic pain. Risk factors for developing fibroids include:
• Increased risk of obesity or being overweight.
• Possible occurrence at any age.
• Most commonly develops between ages 30 and 50 and may persist through menopause.
Fibroids, also known as myomas or leiomyomas, are non-cancerous tumors that rarely develop into cancer. They are most common in women during their childbearing years and can grow within or along the wall of the uterus.
Over 30% of women will experience fibroids at some point in their lives, with the condition most prevalent between ages 30 and 50. Obesity or being overweight increases the risk of fibroids due to higher estrogen levels, which can promote their growth.
Women who have had children, particularly more than one, have a lower risk of developing fibroids.
Fibroids are classified based on their location in the uterus. Understanding these types is crucial for effective management:
Intramural Fibroids
These are the most common type, located within the muscular wall of the uterus. They often grow larger and can stretch the uterine wall.
Subserosal Fibroids
Also known as serosal fibroids, these occur on the outer surface of the uterus. They can expand outward, making the uterus appear enlarged.
Pedunculated Fibroids
These are subserosal fibroids with a stalk or "peduncle" that supports them. They may appear as a fibroid on a slender base.
Submucosal Fibroids
These are less common and develop just beneath the lining of the uterine cavity. They can cause significant symptoms if they grow large.
Various factors such as hormonal changes, family history, and pregnancy can influence fibroid development. Proper diagnosis and treatment are essential to manage fibroids effectively and prevent complications. Modern diagnostic tools can help identify fibroids and guide appropriate treatment.
Determining the exact cause of uterine fibroids can be challenging, and gynecologists have not fully explained why these tumors fluctuate in size. However, several factors are believed to contribute to their growth:
Hormone Factors
Estrogen and progesterone, the hormones that stimulate the uterine lining for pregnancy preparation, also promote fibroid growth.
Genetic Changes
Fibroids may be hereditary, as some researchers have found genetic variations in fibroid cells compared to normal uterine cells. However, conclusive evidence linking genetics to fibroid development is lacking.
Growth Factors
Substances like insulin-like growth factors, which aid tissue maintenance, may influence fibroid growth.
While fibroids typically do not interfere with conception, certain types, such as submucosal fibroids, can cause infertility or pregnancy loss. Large intramural fibroids (greater than 4 cm) may also impact fertility.
Uterine fibroids can increase the risk of several pregnancy complications. Here are some potential dangers:
Restricted Fetal Growth:
Large fibroids can reduce the space in the womb, limiting the embryo's ability to grow properly.
Placental Abruption:
Fibroids may block the uterine wall, leading to placental abruption. This condition can reduce the supply of nutrients and oxygen to the fetus.
Preterm Delivery:
Increased fibroid size can cause pain and uterine contractions, potentially leading to early delivery.
Breach Position:
Fibroids can alter the shape of the uterine cavity, which may affect the baby's position, making standard delivery difficult.
Cesarean Delivery:
Women with fibroids are six to seven times more likely to require a cesarean section compared to those without fibroids.
Miscarriage:
The risk of miscarriage is doubled for women with fibroids.
The symptoms of uterine fibroids can vary depending on their size, location, and number. In many cases, fibroids cause no symptoms and may be found incidentally during a pelvic exam or ultrasound. For symptomatic women, common symptoms include:
• Heavy menstrual bleeding
• Extended menstrual periods lasting more than seven days
• Bloating in the lower abdomen
• Pressure or pain in the pelvic area
• Constipation
• Increased frequency of urination
• Pain during sex
• Difficulty conceiving, or issues such as miscarriage and preterm delivery
Fibroids are often first detected through an ultrasound. To assess their impact on fertility, additional imaging techniques such as a saline infusion sonogram or Hysterosalpingogram (HSG) may be used.
Diagnosis is confirmed through various tests, including Hysterosalpingography, blood tests, and ultrasounds.
Treatment for uterine fibroids is usually recommended only if they cause symptoms. If a fibroid is asymptomatic and does not alter the shape of the uterine cavity, treatment may not be necessary. However, if symptoms are present or the fibroid affects the uterine cavity, medical intervention is advised.
Options include:
• Medications: Hormonal treatments like Gn-RH agonists can shrink fibroids by inducing a temporary postmenopausal state, stopping menstruation, and improving anemia. Progestin-releasing IUDs can also relieve heavy bleeding.
• Surgery: Hysterectomy, which removes the uterus, is a permanent solution often recommended if the patient’s family is complete. Alternatively, a myomectomy can remove fibroids while preserving the uterus. This can be done laparoscopically or via open surgery, with laparoscopic procedures offering faster recovery.
• Non-Invasive and Minimally Invasive Procedures: Magnetic Resonance-guided Focused Ultrasound (MRgFUS) uses ultrasound to destroy fibroid tissue. Uterine artery embolization involves blocking blood supply to fibroids, causing them to shrink.
Treatment options depend on the fibroids' number, size, symptoms, and the patient's overall health.
See how we combine technology and compassion in our care
